Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
EBS
|
Fuad El Hibri
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.75% |
$1,808,800
$90.44 p/Share
|
Nov 02
2020 |
|
SHAK
|
Daniel Harris Meyer
Director |
SELL
Open market or private sale
|
Indirect | 75,000 Reduced 1.85% |
$4,953,750
$66.05 p/Share
|
Nov 02
2020 |
|
MYRG
|
Betty R. Johnson
Senior VP |
SELL
Open market or private sale
|
Direct | 6,264 Reduced 15.97% |
$272,484
$43.5 p/Share
|
Nov 02
2020 |
|
FSLY
|
Artur Bergman
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 92,308 Reduced 24.24% |
$5,971,405
$64.69 p/Share
|
Nov 02
2020 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 6,640 Reduced 25.11% |
$407,497
$61.37 p/Share
|
Nov 02
2020 |
|
XPEL
|
Ryan Pape
President and CEO |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 0.63% |
$200,880
$25.11 p/Share
|
Nov 02
2020 |
|
CASH
|
Michael Robert Kramer
Director |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 18.01% |
$221,175
$29.49 p/Share
|
Nov 02
2020 |
|
CASH
|
William David Tull
Director |
SELL
Open market or private sale
|
Indirect | 68,000 Reduced 36.96% |
$2,007,360
$29.52 p/Share
|
Nov 02
2020 |
|
MGNI
|
Adam Lee Soroca
CHIEF PRODUCT OFFICER |
SELL
Open market or private sale
|
Direct | 10,365 Reduced 2.48% |
$95,565
$9.22 p/Share
|
Nov 02
2020 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct | 6,772 Reduced 100.0% |
$310,225
$45.81 p/Share
|
Nov 02
2020 |
|
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.22% |
$40,194
$18.27 p/Share
|
Nov 02
2020 |
|
LPSN
|
John De Neen Collins
CFO and COO |
SELL
Open market or private sale
|
Direct | 504 Reduced 1.79% |
$26,949
$53.47 p/Share
|
Nov 02
2020 |
|
LPSN
|
William Wesemann
Director |
SELL
Open market or private sale
|
Indirect | 2,500 Reduced 50.0% |
$132,750
$53.1 p/Share
|
Nov 02
2020 |
|
NGM
|
Jin Long Chen
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 2.65% |
$442,500
$17.7 p/Share
|
Nov 02
2020 |
|
RDFN
|
Bridget Frey
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 3.64% |
$168,880
$42.22 p/Share
|
Nov 02
2020 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 7,736 Reduced 0.57% |
$200,130
$25.87 p/Share
|
Nov 02
2020 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 7,777 Reduced 70.3% |
$201,113
$25.86 p/Share
|
Nov 02
2020 |
|
CMCO
|
Alan S Korman
Sr VP, Gen'l Counsel & Sec |
SELL
Open market or private sale
|
Direct | 3,721 Reduced 10.19% |
$126,849
$34.09 p/Share
|
Nov 02
2020 |
|
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 11.68% |
$365,178
$33.97 p/Share
|
Nov 02
2020 |
|
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,242 Reduced 8.12% |
$76,228
$34.0 p/Share
|
Nov 02
2020 |
|
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 23,315 Reduced 100.0% |
$1,346,908
$57.77 p/Share
|
Nov 02
2020 |
|
WINA
|
Brett D Heffes
CHAIR AND CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.46% |
$874,650
$174.93 p/Share
|
Nov 02
2020 |
|
WINA
|
Anthony D Ishaug
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 9.06% |
$435,200
$174.08 p/Share
|
Nov 02
2020 |
|
COWN
|
Jeffrey M Solomon
CHAIR AND CEO |
SELL
Open market or private sale
|
Direct | 10,014 Reduced 1.19% |
$221,209
$22.09 p/Share
|
Nov 02
2020 |
|
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,250 Reduced 1.52% |
$100,250
$16.04 p/Share
|
Nov 02
2020 |
|
STOK
|
Stephen J Tulipano
Former CFO |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 98.31% |
$1,319,500
$37.7 p/Share
|
Nov 02
2020 |
|
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 100.0% |
$212,553
$37.29 p/Share
|
Nov 02
2020 |
|
BAND
|
Kade Ross
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 10.79% |
$78,835
$157.67 p/Share
|
Nov 02
2020 |
|
AMRK
|
Thor Gjerdrum
President |
SELL
Open market or private sale
|
Direct | 7,505 Reduced 100.0% |
$229,278
$30.55 p/Share
|
Nov 02
2020 |
|
KPTI
|
Christopher Brett Primiano
EVP, CBO, GC & Secretary |
SELL
Open market or private sale
|
Direct | 772 Reduced 14.58% |
$11,518
$14.92 p/Share
|
Nov 02
2020 |
|
BLUE
|
Alison Cecily Finger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 35 Reduced 0.13% |
$1,876
$53.59 p/Share
|
Nov 02
2020 |
|
BLUE
|
Joanne Smith Farrell
COO, Oncology |
SELL
Open market or private sale
|
Direct | 37 Reduced 0.17% |
$1,983
$53.59 p/Share
|
Nov 02
2020 |
|
BLUE
|
Jason Cole
Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct | 37 Reduced 0.1% |
$1,983
$53.59 p/Share
|
Nov 02
2020 |
|
BLUE
|
Philip D Gregory
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 59 Reduced 0.16% |
$3,162
$53.59 p/Share
|
Nov 02
2020 |
|
BLUE
|
David Davidson
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 63 Reduced 0.16% |
$3,376
$53.59 p/Share
|
Nov 02
2020 |
|
BLUE
|
Nick Leschly |
SELL
Open market or private sale
|
Direct | 444 Reduced 0.45% |
$23,794
$53.59 p/Share
|
Nov 02
2020 |
|
EVER
|
David W Mason
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.56% |
$68,520
$34.26 p/Share
|
Nov 02
2020 |
|
PRTHW
|
Sean Kiewiet
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 476 Reduced 0.02% |
$1,380
$2.9 p/Share
|
Nov 02
2020 |
|
ZYME
|
Ali Tehrani
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 3,500 Reduced 5.85% |
$136,640
$39.04 p/Share
|
Nov 02
2020 |
|
KALV
|
Edward P. Feener
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 7.62% |
$102,840
$17.14 p/Share
|
Nov 02
2020 |
|
CURO
|
Donald Gayhardt
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 478 Reduced 0.06% |
$3,824
$8.0 p/Share
|
Nov 02
2020 |
|
OVLY
|
Ronald C. Martin
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.52% |
$13,980
$13.98 p/Share
|
Nov 02
2020 |
|
TCMD
|
William W Burke
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 20.43% |
$56,250
$37.5 p/Share
|
Nov 02
2020 |
|
CFMS
|
Mark A Augusti
FORMER PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 64,065 Reduced 2.61% |
$41,642
$0.65 p/Share
|
Nov 02
2020 |
|
EGIO
|
Robert A Lento
CEO |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 1.13% |
$73,540
$3.53 p/Share
|
Nov 02
2020 |
|
SC
|
Shawn Allgood
Officer |
SELL
Open market or private sale
|
Direct | 10,033 Reduced 34.63% |
$211,797
$21.11 p/Share
|
Nov 02
2020 |
|
WORK
|
Robert Frati
Sr VP Sales, Customer Success |
SELL
Open market or private sale
|
Direct | 12,449 Reduced 3.81% |
$313,217
$25.16 p/Share
|
Nov 02
2020 |
|
WORK
|
Brandon Zell
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 4,016 Reduced 2.23% |
$101,043
$25.16 p/Share
|
Nov 02
2020 |
|
WORK
|
David Schellhase
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 3,347 Reduced 1.12% |
$84,211
$25.16 p/Share
|
Nov 02
2020 |
|
WORK
|
Allen Shim
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 28,439 Reduced 9.81% |
$715,525
$25.16 p/Share
|
Nov 02
2020 |